Hang Lung Group 将来の成長

このセクションでは通常、投資家が会社の利益創出能力を理解する一助となるよう、プロのアナリストのコンセンサス予想に基づく収益と利益の成長予測を提示する。しかし、Hang Lung Group は十分な過去のデータを提供しておらず、アナリストの予測もないため、過去のデータを外挿したり、アナリストの予測を使用しても、その将来の収益を確実に算出することはできません。

シンプリー・ウォール・ストリートがカバーする企業の97%は過去の財務データを持っているため、これはかなり稀な状況です。

業績と収益の成長予測

SEHK:10 - アナリストの将来予測と過去の財務データ ( )HKD Millions
日付	収益	収益	フリー・キャッシュフロー	営業活動によるキャッシュ	平均アナリスト数
6/30/2024	11,924	2,017	3,814	3,814	N/A
3/31/2024	11,466	2,414	3,918	3,918	N/A
12/31/2023	11,008	2,811	4,022	4,022	N/A
9/30/2023	10,941	2,886	4,394	4,394	N/A
6/30/2023	10,874	2,961	4,766	4,766	N/A
3/31/2023	10,937	2,840	4,605	4,605	N/A
12/31/2022	11,000	2,718	4,443	4,443	N/A
9/30/2022	11,191	2,619	4,665	4,665	N/A
6/30/2022	11,382	2,520	4,887	4,887	N/A
3/31/2022	11,144	2,555	3,965	3,965	N/A
12/31/2021	10,905	2,589	3,043	3,043	N/A
9/30/2021	10,547	2,076	2,668	2,668	N/A
6/30/2021	10,189	1,562	2,292	2,292	N/A
3/31/2021	9,712	11	3,027	3,027	N/A
12/31/2020	9,235	-1,541	3,761	3,761	N/A
9/30/2020	9,257	-14	4,380	4,380	N/A
6/30/2020	9,279	1,512	4,998	4,998	N/A
3/31/2020	9,449	4,164	5,348	5,348	N/A
12/31/2019	9,618	6,816	5,698	5,698	N/A
9/30/2019	9,484	6,387	5,353	5,353	N/A
6/30/2019	9,349	5,957	5,007	5,007	N/A
3/31/2019	9,900	5,621	5,556	5,556	N/A
12/31/2018	10,450	5,285	6,104	6,104	N/A
9/30/2018	10,729	5,620	5,942	5,942	N/A
6/30/2018	11,007	5,955	5,780	5,780	N/A
3/31/2018	11,501	5,635	N/A	7,309	N/A
12/31/2017	11,995	5,314	N/A	8,837	N/A
9/30/2017	12,887	4,817	N/A	9,666	N/A
6/30/2017	13,778	4,319	N/A	10,495	N/A
3/31/2017	13,778	4,016	N/A	8,762	N/A
12/31/2016	13,777	3,713	N/A	7,028	N/A
9/30/2016	12,625	3,468	N/A	6,696	N/A
6/30/2016	11,473	3,222	N/A	6,364	N/A
3/31/2016	10,629	3,217	N/A	6,182	N/A
12/31/2015	9,784	3,211	N/A	5,999	N/A
9/30/2015	13,905	4,878	N/A	9,904	N/A
6/30/2015	18,025	6,544	N/A	13,809	N/A
3/31/2015	17,993	6,685	N/A	14,632	N/A
12/31/2014	17,961	6,825	N/A	15,454	N/A
9/30/2014	14,654	5,838	N/A	11,493	N/A
6/30/2014	11,346	4,851	N/A	7,531	N/A
3/31/2014	10,756	4,704	N/A	6,352	N/A
12/31/2013	10,165	4,557	N/A	5,172	N/A

アナリストによる今後の成長予測

収入対貯蓄率: 10の予測収益成長が貯蓄率 ( 2.3% ) を上回っているかどうかを判断するにはデータが不十分です。

収益対市場: 10の収益がHong Kong市場よりも速く成長すると予測されるかどうかを判断するにはデータが不十分です

高成長収益: 10の収益が今後 3 年間で大幅に増加すると予想されるかどうかを判断するにはデータが不十分です。

収益対市場: 10の収益がHong Kong市場よりも速く成長すると予測されるかどうかを判断するにはデータが不十分です。

高い収益成長: 10の収益が年間20%よりも速く成長すると予測されるかどうかを判断するにはデータが不十分です。

一株当たり利益成長率予想

将来の株主資本利益率

将来のROE: 10の自己資本利益率が 3 年後に高くなると予測されるかどうかを判断するにはデータが不十分です

Hang Lung Group 将来の成長

Future 基準チェック /06

主要情報

今後の成長に関する最新情報

Recent updates

Investor sentiment improves as stock rises 17%

Investors Can Find Comfort In Hang Lung Group's (HKG:10) Earnings Quality

First half 2024 earnings released: EPS: HK$0.65 (vs HK$1.24 in 1H 2023)

Executive Chair of the Board recently bought HK$504k worth of stock

Executive Chair of the Board recently bought HK$334k worth of stock

Upcoming dividend of HK$0.21 per share

First half 2024 earnings released: EPS: HK$0.65 (vs HK$1.24 in 1H 2023)

Hang Lung Group Limited to Report First Half, 2024 Results on Jul 30, 2024

Hang Lung Group Limited Announces Audit Committee Changes, Effective July 1, 2024

Upcoming dividend of HK$0.65 per share

Full year 2023 earnings released: EPS: HK$2.06 (vs HK$2.00 in FY 2022)

Hang Lung Group (HKG:10) Takes On Some Risk With Its Use Of Debt

Executive Vice Chair of the Board recently bought HK$941k worth of stock

Hang Lung Group (HKG:10) Is Due To Pay A Dividend Of HK$0.65

Final dividend of HK$0.65 announced

Full year 2023 earnings released: EPS: HK$2.06 (vs HK$2.00 in FY 2022)

Hang Lung Properties Limited and Hang Lung Group Limited Announce Retirement of Mr. Ronnie Chichung Chan as the Chair, an Executive Director, and the Chair of Executive Committees, with Effect from April 26, 2024

Hang Lung Group Limited Appoints Ms. May Siew Boi Tan as an Independent Non-Executive Director, with Effect from March 20, 2024

Hang Lung Group Limited to Report Fiscal Year 2023 Results on Jan 30, 2024

Investors Continue Waiting On Sidelines For Hang Lung Group Limited (HKG:10)

Hang Lung Group (HKG:10) Takes On Some Risk With Its Use Of Debt

Hang Lung Group (HKG:10) Has Announced A Dividend Of HK$0.21

Upcoming dividend of HK$0.21 per share at 7.8% yield

Hang Lung Group (HKG:10) Is Paying Out A Dividend Of HK$0.21

CEO & Executive Director recently bought HK$542k worth of stock

Hang Lung Group (HKG:10) Will Pay A Dividend Of HK$0.21

First half 2023 earnings released: EPS: HK$1.24 (vs HK$1.06 in 1H 2022)

Hang Lung Group Limited Announces Interim Dividend for the Six Months Ended 30 June 2023, Payable on 29 September 2023

Hang Lung Group Limited to Report First Half, 2023 Results on Jul 31, 2023

These 4 Measures Indicate That Hang Lung Group (HKG:10) Is Using Debt Extensively

Upcoming dividend of HK$0.65 per share at 6.3% yield

Full year 2022 earnings released: EPS: HK$2.00 (vs HK$1.90 in FY 2021)

Hang Lung Group (HKG:10) Is Due To Pay A Dividend Of HK$0.65

Hang Lung Group (HKG:10) Is Paying Out A Dividend Of HK$0.65

Hang Lung Group Limited Proposes Final Dividend for the Year Ended 31 December 2022, Payable on 19 May 2023

Full year 2022 earnings released: EPS: HK$2.00 (vs HK$1.90 in FY 2021)

Less than half of directors are independent

Does Hang Lung Group (HKG:10) Have A Healthy Balance Sheet?

First half 2022 earnings released: EPS: HK$1.06 (vs HK$1.11 in 1H 2021)

Upcoming dividend of HK$0.21 per share

CEO & Executive Director recently bought HK$678k worth of stock

Hang Lung Group (HKG:10) Is Due To Pay A Dividend Of HK$0.21

Hang Lung Group Limited Announces Interim Dividend for the Six Months Ended 30 June 2022, Payable on 29 September 2022

First half 2022 earnings released

Hang Lung Group Limited to Report First Half, 2022 Results on Jul 28, 2022

Calculating The Intrinsic Value Of Hang Lung Group Limited (HKG:10)

Hang Lung Group Limited Approves Final Dividend

Less than half of directors are independent

Does Hang Lung Group (HKG:10) Have A Healthy Balance Sheet?

Now 20% undervalued after recent price drop

Hang Lung Group Limited Proposes Final Dividend for the Year Ended December 31, 2021, Payable on May 19, 2022

Full year 2021 earnings: EPS and revenues miss analyst expectations

Hang Lung Group Limited, Annual General Meeting, Apr 27, 2022

Is Hang Lung Group (HKG:10) A Risky Investment?

First half 2021 earnings released: EPS HK$1.11 (vs HK$1.17 loss in 1H 2020)

CEO & Executive Director recently bought HK$2.8m worth of stock

Upcoming dividend of HK$0.21 per share

CFO & Executive Director recently bought HK$562k worth of stock

CFO & Executive Director recently bought HK$417k worth of stock

First half 2021 earnings released: EPS HK$1.11 (vs HK$1.17 loss in 1H 2020)

Calculating The Fair Value Of Hang Lung Group Limited (HKG:10)

Director of General Counsel has left the company

Hang Lung Group Limited Declares Final Dividend for the Year 2020

Upcoming dividend of HK$0.63 per share

Shareholders May Be Wary Of Increasing Hang Lung Group Limited's (HKG:10) CEO Compensation Package

Full year 2020 earnings released: HK$1.13 loss per share (vs HK$5.01 profit in FY 2019)

These 4 Measures Indicate That Hang Lung Group (HKG:10) Is Using Debt Extensively

Are Dividend Investors Making A Mistake With Hang Lung Group Limited (HKG:10)?

Full year 2020 earnings released: HK$1.13 loss per share (vs HK$5.01 profit in FY 2019)

Hang Lung Group Limited, Annual General Meeting, Apr 30, 2021

What Kind Of Investors Own Most Of Hang Lung Group Limited (HKG:10)?

New 90-day high: HK$20.55

Would Shareholders Who Purchased Hang Lung Group's (HKG:10) Stock Three Years Be Happy With The Share price Today?

Hang Lung Group Limited to Report Fiscal Year 2020 Results on Jan 28, 2021

How Much Are Hang Lung Group Limited (HKG:10) Insiders Spending On Buying Shares?